Home › Funds › Kalehua Capital Management LLC › XFOR
Kalehua Capital Management LLC position in XFOR
X4 PHARMACEUTICALS INC · Health Care
Kalehua Capital Management LLC reported holding 3,722,840 shares of XFOR (X4 PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$10.8M, representing 8.15% of its reported portfolio and ranking #4 among its reported holdings. Kalehua Capital Management LLC has disclosed XFOR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Kalehua Capital Management LLC's XFOR position evolved
Kalehua Capital Management LLC first disclosed a stake in XFOR in Q4 2025 at 3,722,840 shares (US$14.9M). The position peaked in Q2 2026 at 3,722,840 shares, worth US$17.4M. Across 4 filings, Kalehua Capital Management LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 3,722,840 shares valued at US$10.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 3.72M | $14.89M | New |
| Q1 2026 | 3.72M | $15.38M | Hold |
| Q2 2026 | 3.72M | $17.39M | Hold |
| Q3 2026 | 3.72M | $10.80M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About XFOR and 13F data
XFOR (X4 PHARMACEUTICALS INC) is a Health Care company. 35 other funds we track also report a position in XFOR — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$37.2M), PERCEPTIVE ADVISORS LLC (US$37.0M), Saturn V Capital Management LP (US$32.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding XFOR
- Bain Capital Life Sciences Investors, LLC 7.97M sh · $37.21M · Q2 2026
- PERCEPTIVE ADVISORS LLC 7.93M sh · $37.05M · Q2 2026
- Saturn V Capital Management LP 6.97M sh · $32.57M · Q2 2026
- Empery Asset Management, LP 6.93M sh · $32.37M · Q2 2026
- Deep Track Capital, LP 5.88M sh · $27.45M · Q2 2026
- NEA Management Company, LLC 3.23M sh · $15.10M · Q2 2026
- Rosalind Advisors, Inc. 3.21M sh · $15.01M · Q2 2026
- Trails Edge Capital Partners, LP 2.57M sh · $12.01M · Q2 2026
- BVF INC/IL 2.23M sh · $10.43M · Q2 2026
- Venrock Adviser, LLC 1.93M sh · $9.03M · Q2 2026
- Samsara BioCapital, LLC 1.40M sh · $6.52M · Q2 2026
- Verdad Advisers, LP 352.09K sh · $1.64M · Q2 2026
More on Kalehua Capital Management LLC
FAQ
How long has Kalehua Capital Management LLC held XFOR?
Kalehua Capital Management LLC has disclosed XFOR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Kalehua Capital Management LLC's current position in XFOR?
As of Q3 2026, Kalehua Capital Management LLC holds 3.72M shares of XFOR (X4 PHARMACEUTICALS INC), valued at $10.80M, representing 8.15% of its reported portfolio and ranking #4.
Has Kalehua Capital Management LLC been buying or selling XFOR?
In the latest 13F filing (Q3 2026), Kalehua Capital Management LLC held unchanged its position in XFOR. The position peaked in Q2 2026 at 3.72M shares.
Which other funds hold XFOR?
Other major institutional holders of XFOR include Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, Saturn V Capital Management LP, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.